| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 12/15/2004 | CN1555264A Formulations for treatment of mucosal associated conditions with an immune response modifier |
| 12/15/2004 | CN1555262A Novel 4,5-dihydro-1H-pyrazole derivatives having CB*-antagonistic activity |
| 12/15/2004 | CN1555256A Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 12/15/2004 | CN1554438A Medicine for strengthening spleen, regulating stomach, promoting digestion and removing stagnated food |
| 12/15/2004 | CN1554434A Chinese medicine and Hui medicine preparation for treating cholecystitis and its preparing method |
| 12/15/2004 | CN1554432A Yinzhihuang injection preparation and its preparing method |
| 12/15/2004 | CN1554429A Medicine powder for liver and spleen diseases |
| 12/15/2004 | CN1554406A Medicine for tonifying kidney, strengthening spleen, replenishing esseuce and invigorating marrow and its preparing method |
| 12/15/2004 | CN1554403A Maitong pill |
| 12/15/2004 | CN1554391A Medicine for preventing proctoptosis and its preparing method |
| 12/15/2004 | CN1554384A Medicine for treating hepatitis B |
| 12/15/2004 | CN1554382A Medicine liqid for curing hepatopathy |
| 12/15/2004 | CN1554370A Medicine for treating virus hepatitis and its preparing method |
| 12/15/2004 | CN1554366A Method for preparing compound oral liquid having self anti rot fumction |
| 12/15/2004 | CN1554364A Process for preparing liuwei Dihuang preparation |
| 12/15/2004 | CN1554363A Anti-hepatitis b placenta specific factor extract with specific immunological activity and its preparing process |
| 12/15/2004 | CN1554358A Dibutyryl cyclic adenosine monophosphate preparation and preparing method |
| 12/15/2004 | CN1554356A Method for preparing baicalin liquid |
| 12/15/2004 | CN1554349A Dry mix formulation for bisphosphonic acids |
| 12/15/2004 | CN1554339A Matrine enteric soluble hard capsule and its preparing method |
| 12/15/2004 | CN1554327A Plaster for promoting peristalsis and urination after operation |
| 12/15/2004 | CN1179970C Purine derivatives |
| 12/15/2004 | CN1179961C Sulfonamides for treatment of endothelin-mediated disorders |
| 12/15/2004 | CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications |
| 12/15/2004 | CN1179958C Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 12/15/2004 | CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them |
| 12/15/2004 | CN1179746C Medicine for curing cardio-cerebrovascular disease |
| 12/15/2004 | CN1179745C Chinese medicine preparation for curing choleithiasis and cholecystitis and production method thereof |
| 12/15/2004 | CN1179743C Sore-eliminating medicine powder and its prepn and usage |
| 12/15/2004 | CN1179736C Chinese medicine for curing gastropathy |
| 12/15/2004 | CN1179735C Litholytic medicine for treating hepatolith and preparation process thereof |
| 12/15/2004 | CN1179731C Medicine for treating dental diseases |
| 12/14/2004 | US6831186 Antiinflammatory agents; autoimmune disease |
| 12/14/2004 | US6831105 For therapy and prophylaxis of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/14/2004 | US6831097 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 12/14/2004 | US6831085 Methods and compositions utilizing quinazolinones |
| 12/14/2004 | US6831080 Cinnamide derivatives as KCNQ potassium channel modulators |
| 12/14/2004 | US6831069 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 12/14/2004 | US6831065 Anti-inflammatory compounds and uses thereof |
| 12/14/2004 | US6830743 In Vivo stain compounds and methods of use to identify dysplastic tissue |
| 12/14/2004 | CA2180867C Monomeric diols and phosphate linked oligomers formed therefrom |
| 12/09/2004 | WO2004106938A2 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7) |
| 12/09/2004 | WO2004106935A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 103 (gpr103) |
| 12/09/2004 | WO2004106934A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 12/09/2004 | WO2004106382A1 Antibody and use thereof |
| 12/09/2004 | WO2004106321A1 4-aryl-5h-thiophene-2-one derivatives and its preparation and use |
| 12/09/2004 | WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof |
| 12/09/2004 | WO2004106306A1 Novel ureido - and amido-pyrazolone derivatives |
| 12/09/2004 | WO2004106290A1 Amino alcohol derivatives, phamaceutical compositions containing the same, and use of both |
| 12/09/2004 | WO2004106283A1 Amino alcohol derivative, medicinal composition containing the same, and uses of these |
| 12/09/2004 | WO2004106280A1 CaSR ANTAGONIST |
| 12/09/2004 | WO2004105795A1 Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility |
| 12/09/2004 | WO2004105792A1 Composition against parvovirus infection |
| 12/09/2004 | WO2004105760A1 Use of efletirizine for treating persistent allergic rhinitis |
| 12/09/2004 | WO2004105737A2 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents |
| 12/09/2004 | WO2004080446B1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine |
| 12/09/2004 | WO2004078175A3 Pharmaceutical preparations containing thiazolidinediones for the treatment or prevention of ip-10 mediated diseases |
| 12/09/2004 | WO2004024168A8 Composition and method for use in intestinal cleansing procedures |
| 12/09/2004 | WO2003105800A3 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/09/2004 | WO2003097082A3 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies |
| 12/09/2004 | WO2003097051A3 Use of compounds that are effective as selective opiate receptor modulators |
| 12/09/2004 | WO2003082898A3 Novel analogues of glucose-dependent insulinotropic polypeptide |
| 12/09/2004 | WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 12/09/2004 | US20040249167 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 12/09/2004 | US20040249161 Biphenyl-derivatives as p38-kinase inhibitors |
| 12/09/2004 | US20040249159 Novel piperidin-2,6-dione disulphate salts and their use for the treatment of stress related affective disorders |
| 12/09/2004 | US20040249153 For therapy of inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors |
| 12/09/2004 | US20040249132 Nuclear hormone receptor ligand binding domain |
| 12/09/2004 | US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders |
| 12/09/2004 | US20040248980 Method of treatment for irritable bowel syndrome |
| 12/09/2004 | US20040248967 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same |
| 12/09/2004 | US20040248944 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 12/09/2004 | US20040248941 such as 4-[2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazol-1-yl]-1,3-dioxolan-2-one, used as prodrugs to lansoprazole; proton pump inhibitors; antiulcer agents |
| 12/09/2004 | US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents |
| 12/09/2004 | US20040248927 Preventive agent/remedial agent for constipation predominant ibs |
| 12/09/2004 | US20040248923 Novel 4-anilinoquinoline-3-carboxamides |
| 12/09/2004 | US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 12/09/2004 | US20040248902 Central nervous system, gastrointestinal and psycological disorders; such as 3-(4-chlorobenzenesulfonyl)-2-methyl-7-piperazin-1-yl-1H-indole; synthesis |
| 12/09/2004 | US20040248889 Analgesics; synthesis |
| 12/09/2004 | US20040248886 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide |
| 12/09/2004 | US20040248885 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 12/09/2004 | US20040248883 Novel heteroaryl derivatives, their preparation and use |
| 12/09/2004 | US20040248876 Reducing islet amyloid polypeptide (IAPP) associated deposit; type II diabetes |
| 12/09/2004 | US20040248820 Administering 2-phthalimidoglutaric acid; vision defects; antitumor agents; anticancer agents |
| 12/09/2004 | US20040248810 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 12/09/2004 | US20040248782 Long lasting glucagon-like peptide2(glp-2)for the treatment of gastrointestinal diseases and disorders |
| 12/09/2004 | US20040248768 Nutritional composition preventing bacterial overgrowth |
| 12/09/2004 | US20040248321 Membrane protein for use in treatment and prevention of inflammatory, circulatory, cell proliferative, metabolic and immunological disorders |
| 12/09/2004 | US20040248278 Streptococcus expressing lymphocytic protein for use in prevention and treatment of insulin resistance, obesity, autism and attention deficit/hyperactivity disorders |
| 12/09/2004 | US20040248252 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 12/09/2004 | US20040248251 Receptors and membrane associated proteins |
| 12/09/2004 | US20040248243 Lipid metabolizing polypeptide for use in identifying modulators for treatment and prevention of cancer, nervous system, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 12/09/2004 | US20040248208 Screening method |
| 12/09/2004 | US20040248188 Methods for using tetanus toxin for benificial purposes in animals (mammals) |
| 12/09/2004 | US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 12/09/2004 | US20040247643 A miniature coated tablet or covered rod implant; smaller size and larger payloads than immediate release tablets; veterinary medicine |
| 12/09/2004 | US20040247532 NaCl, KCl, NaHCO3, monobasic or dibasic potassium phosphate saliva substitute; triclosan, chlorhexidine or benzalkonium and salts, or cetylpyridium chloride antiseptic; NaF, Na2PO3F, or xylitol anticariogenic agent; vitamin E acetate, panthenol, dipotassium glycyrrhizinate, or aloe vera extract |
| 12/09/2004 | CA2527429A1 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents |
| 12/09/2004 | CA2527194A1 Novel ureido - and amido-pyrazolone derivatives |
| 12/09/2004 | CA2526566A1 Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility |